313 related articles for article (PubMed ID: 27207011)
1. Clinical-scale expansion of mesenchymal stromal cells: a large banking experience.
Lechanteur C; Briquet A; Giet O; Delloye O; Baudoux E; Beguin Y
J Transl Med; 2016 May; 14(1):145. PubMed ID: 27207011
[TBL] [Abstract][Full Text] [Related]
2. The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes.
Oja S; Kaartinen T; Ahti M; Korhonen M; Laitinen A; Nystedt J
Front Immunol; 2019; 10():1627. PubMed ID: 31379832
[TBL] [Abstract][Full Text] [Related]
3. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation.
Luetzkendorf J; Nerger K; Hering J; Moegel A; Hoffmann K; Hoefers C; Mueller-Tidow C; Mueller LP
Cytotherapy; 2015 Feb; 17(2):186-98. PubMed ID: 25593077
[TBL] [Abstract][Full Text] [Related]
5. Manufacturing and banking of mesenchymal stem cells.
Thirumala S; Goebel WS; Woods EJ
Expert Opin Biol Ther; 2013 May; 13(5):673-91. PubMed ID: 23339745
[TBL] [Abstract][Full Text] [Related]
6. MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process.
Lechanteur C; Briquet A; Bettonville V; Baudoux E; Beguin Y
Cells; 2021 May; 10(6):. PubMed ID: 34073206
[TBL] [Abstract][Full Text] [Related]
7. Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use.
Amati E; Sella S; Perbellini O; Alghisi A; Bernardi M; Chieregato K; Lievore C; Peserico D; Rigno M; Zilio A; Ruggeri M; Rodeghiero F; Astori G
Stem Cell Res Ther; 2017 Jan; 8(1):14. PubMed ID: 28115021
[TBL] [Abstract][Full Text] [Related]
8. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells.
Codinach M; Blanco M; Ortega I; Lloret M; Reales L; Coca MI; Torrents S; Doral M; Oliver-Vila I; Requena-Montero M; Vives J; Garcia-López J
Cytotherapy; 2016 Sep; 18(9):1197-208. PubMed ID: 27424149
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cells.
Wuchter P; Vetter M; Saffrich R; Diehlmann A; Bieback K; Ho AD; Horn P
Exp Hematol; 2016 Jun; 44(6):508-18. PubMed ID: 26911671
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation and Revival of Human Mesenchymal Stromal Cells.
Haack-Sørensen M; Ekblond A; Kastrup J
Methods Mol Biol; 2016; 1416():357-74. PubMed ID: 27236683
[TBL] [Abstract][Full Text] [Related]
11. A new standardized clinical-grade protocol for banking human umbilical cord tissue cells.
Fazzina R; Mariotti A; Procoli A; Fioravanti D; Iudicone P; Scambia G; Pierelli L; Bonanno G
Transfusion; 2015 Dec; 55(12):2864-73. PubMed ID: 26354088
[TBL] [Abstract][Full Text] [Related]
12. Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture.
Kaplan A; Sackett K; Sumstad D; Kadidlo D; McKenna DH
Transfusion; 2017 Sep; 57(9):2216-2219. PubMed ID: 28653392
[TBL] [Abstract][Full Text] [Related]
13. Clinical grade expansion of MSCs.
Capelli C; Pedrini O; Valgardsdottir R; Da Roit F; Golay J; Introna M
Immunol Lett; 2015 Dec; 168(2):222-7. PubMed ID: 26092523
[TBL] [Abstract][Full Text] [Related]
14. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank.
Chatzistamatiou TK; Papassavas AC; Michalopoulos E; Gamaloutsos C; Mallis P; Gontika I; Panagouli E; Koussoulakos SL; Stavropoulos-Giokas C
Transfusion; 2014 Dec; 54(12):3108-20. PubMed ID: 24894363
[TBL] [Abstract][Full Text] [Related]
15. GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion.
Grisendi G; Annerén C; Cafarelli L; Sternieri R; Veronesi E; Cervo GL; Luminari S; Maur M; Frassoldati A; Palazzi G; Otsuru S; Bambi F; Paolucci P; Pierfranco C; Horwitz E; Dominici M
Cytotherapy; 2010 Jul; 12(4):466-77. PubMed ID: 20353309
[TBL] [Abstract][Full Text] [Related]
16. Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation.
Mamidi MK; Nathan KG; Singh G; Thrichelvam ST; Mohd Yusof NA; Fakharuzi NA; Zakaria Z; Bhonde R; Das AK; Majumdar AS
J Cell Biochem; 2012 Oct; 113(10):3153-64. PubMed ID: 22615164
[TBL] [Abstract][Full Text] [Related]
17. Isolation, Culture, and Characterization of Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells.
Bieback K; Netsch P
Methods Mol Biol; 2016; 1416():245-58. PubMed ID: 27236676
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application.
Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I;
Stem Cells Dev; 2015 Mar; 24(6):677-85. PubMed ID: 25517941
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly.
Oliver-Vila I; Coca MI; Grau-Vorster M; Pujals-Fonts N; Caminal M; Casamayor-Genescà A; Ortega I; Reales L; Pla A; Blanco M; García J; Vives J
Cytotherapy; 2016 Jan; 18(1):25-35. PubMed ID: 26549383
[TBL] [Abstract][Full Text] [Related]
20. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
Samuelsson H; Ringdén O; Lönnies H; Le Blanc K
Cytotherapy; 2009; 11(2):129-36. PubMed ID: 19152151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
